Default Category
-
Hospital Universitari Vall d'Hebron: gestión de la COVID-19 (abreviado)
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, Miguel; Esquerdo, Mariona; Arnal, LaiaCase P-1192Innovation and Change, Service and Operations ManagementEl caso describe los cambios que se produjeron en el Hospital Universitari Vall d'Hebron, el mayor hospital terciario en Barcelona, durante la pandemia de la COVID-19, cuando tuvo que transformarse en un hospital de enfermedades infeccionas dedicado al coronavirus en un tiempo récord, manteniendo el mismo personal. El director gerente del centro reflexiona sobre la preparación para la pandemia, la llegada de los primeros pacientes COVID, el escal...Starting at €8.20
-
Dr. Reddy's Laboratories (B)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M065-EStrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Dr. Reddy's Laboratories (A)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M064-EStrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
COVID-19 Management at Vall d'Hebron University Hospital (Abridged)
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, Miguel; Esquerdo, Mariona; Arnal, LaiaCase P-1192-EInnovation and Change, Service and Operations ManagementThe case describes the changes that occurred at the Vall d'Hebron University Hospital, the largest tertiary hospital in Barcelona, during the beginning of the COVID-19 pandemic, when it had to be transformed into an infectious disease hospital dedicated to the coronavirus in record time and with the same staff as before. The manager of the center reflected on the preparation for the pandemic, the arrival of the first COVID patients, the scaling u...Starting at €8.20
-
Hospital Universitari Vall d'Hebron: gestión de la COVID-19
Ribera, Jaume; Markakis, Mihalis; Zhu, Weiming; Cebrián, MiguelCase P-1188Innovation and Change, Service and Operations ManagementEl caso describe los cambios que se produjeron en el Hospital Universitari Vall d'Hebron, el mayor hospital terciario en Barcelona, durante la pandemia de la COVID-19, cuando tuvo que transformarse en un hospital de enfermedades infeccionas dedicado al coronavirus en un tiempo récord, manteniendo el mismo personal. El director gerente del centro reflexiona sobre la preparación para la pandemia, la llegada de los primeros pacientes COVID, el escal...Starting at €8.20
-
Dr. Reddy's Laboratories (A) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS64StrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Dr. Reddy's Laboratories (B) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS65StrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Schibsted (A): Should We Launch 20 Minutes
Jean-Louis Schaan; Jordan MitchellCase IVEY-9B07M019-EStrategyThe executive vice-president of newspapers for Schibsted was about to meet with his colleagues to discuss the company's plan to release an internally developed free daily newspaper concept called 20 Minutes. Over the past couple of years, Schibsted's executive team had kept a watchful eye on the free newspaper industry, which was enjoying tremendous popularity. Earlier in the year, Schibsted had launched Avis 1, a free paper with direct delivery ...Starting at €8.20